Performance of Amino Acid Positons Emission Tomography in Brain Metastases

Starting soon

Conditions studied: PET-CT

In brief

Differentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications

Key facts

Study ID

NCT07676448

Run by

Central Hospital, Nancy, France

People needed

80

Starts

2026-08-05

Expected to finish

2026-11-03

Last updated by the study team

2026-07-17

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who received a PET amino acid for differentiating radiation necrosis from progression of irradiated brain metastases,

You may not qualify if…

• Patients who refused the using of their data

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.